RNAC · Cartesian Therapeutics, Inc.
Market Cap
$280.47M
Shares
30.26M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Carsten Brunn | President and Chief Executive Officer | $4,329,868 |
| Metin Kurtoglu | M.D., Ph.D. Former Chief Technology Officer | $2,474,034 |
| Christopher Jewell | Former Chief Scientific Officer | $2,015,707 |
| Blaine Davis | Chief Financial Officer | $1,949,927 |
| Milos Miljkovic | Chief Medical Officer | $1,657,535 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Carsten Brunn | President and Chief Executive Officer | $7,314,211 |
| Blaine Davis | Chief Financial Officer | $3,971,412 |
| Metin Kurtoglu | M.D., Ph.D. Chief Technology Officer | $2,713,064 |
| Christopher Jewell | Chief Scientific Officer | $1,687,754 |
| Milos Miljkovic | Chief Medical Officer | $1,349,018 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Carsten Brunn | President and Chief Executive Officer | $6,111,883 |
| Peter G. Traber | Former Chief Medical Officer | $3,780,920 |
| Lloyd Johnston | Former Chief Operations Officer | $2,697,590 |
| Blaine Davis | Chief Financial Officer | $2,494,759 |
| Metin Kurtoglu | M.D., Ph.D. Chief Technology Officer | $71,243 |
| Christopher Jewell | Chief Scientific Officer | $53,100 |
| Chris Jewell | Chief Scientific Officer | $53,100 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Carsten Brunn | President and Chief Executive Officer | $4,292,242 |
| Peter G. Traber | Former Chief Medical Officer | $2,003,983 |
| Kevin Tan | Former Chief Financial Officer | $1,688,429 |
| Takashi Kei Kishimoto | Chief Scientific Officer | $1,684,353 |
| Lloyd Johnston | Former Chief Operations Officer | $1,674,359 |
| Blaine Davis | Chief Financial Officer | $1,263,706 |
| Chris Jewell | Chief Scientific Officer | — |
| Metin Kurtoglu | M.D., Ph.D. Chief Technology Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Carsten Brunn | President and Chief Executive Officer | $3,671,395 |
| Kevin Tan | Former Chief Financial Officer | $2,601,622 |
| Peter G. Traber | Chief Medical Officer | $1,600,685 |
| Takashi Kei Kishimoto | Chief Scientific Officer | $1,306,675 |
| Lloyd Johnston | Chief Operations Officer | $1,304,845 |
| Bradford D. Dahms | Chief Financial Officer | $868,053 |
| Ann K. Donohue | C.P.A. VP, Finance and Corporate Controller, Principal Financial and Accounting Officer | $361,493 |
| Blaine Davis | Chief Financial Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Carsten Brunn | President and Chief Executive Officer | $2,095,347 |
| Peter G. Traber | Chief Medical Officer | $1,512,857 |
| Bradford D. Dahms | Chief Financial Officer | $959,356 |
| Lloyd Johnston | Chief Operations Officer | $889,306 |
| Takashi Kei Kishimoto | Chief Scientific Officer | $807,333 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Carsten Brunn | President and Chief Executive Officer | $1,986,495 |
| Elona Kogan | General Counsel and Corporate Secretary | $1,359,486 |
| Stephen Smolinski | Chief Commercial Officer | $964,635 |
| Bradford D. Dahms | Chief Financial Officer | $768,604 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Carsten Brunn | President and Chief Executive Officer | $5,605,148 |
| Stephen Smolinski | Chief Commercial Officer | $1,236,950 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Milos Miljkovic, M.D. | Chief Medical Officer | Resigned | 2026-05-26 |
| Murat Kalayoglu, M.D., Ph.D. | member of the Board of Directors | Resigned | 2026-03-30 |
| Adrian Bot, M.D., Ph.D. | Class II director | Appointed | 2025-12-18 |
| Patrick Zenner, M.B.A. | Lead Independent Director of the Board | Appointed | 2025-10-30 |
| Kemal Malik, M.B.B.S. | Chairman of the Board’s Compensation Committee | Appointed | 2025-10-30 |
| Patrick Zenner, M.B.A. | Lead Independent Director of the Board | Appointed | 2025-10-30 |
| Carsten Brunn, Ph.D. | Chairman of the Board | Appointed | 2025-10-30 |
| Carrie S. Cox | member of the Board of Directors | Resigned | 2025-10-30 |
| Christopher Jewell, Ph.D. | Chief Scientific Officer | Terminated | 2025-10-21 |
| June Seymour | Chief Accounting Officer | Appointed | 2025-10-08 |
Key facts
CIK
1453687
CUSIP
816212302
13F (30d)
65 filings
65 filers
Visit website
Investor relations